Healthdirect Australia is not responsible for the content and advertising on the external website you are now entering.
Comirnaty Original/Omicron BA.4-5 TM
You should seek medical advice in relation to medicines and use only as directed by a healthcare professional. Always read the label. If symptoms persist see your healthcare professional.
Active ingredients: tozinameran + famtozinameran
Brand name
(ARTG)
: COMIRNATY ORIGINAL/OMICRON BA.4-5 (tozinameran/famtozinameran) COVID-19 VACCINE 15/15 micrograms/0.3 mL suspension for injection vialDownload the Consumer Medicine Information Leaflet
Download consumer medicine information leaflet (pdf) from the Therapeutic Goods Administration (TGA) website
What this medicine is used for
(ARTG)
COMIRNATY Original/Omicron BA.4-5 Vaccine has provisional approval for the indication below:,Active immunisation to prevent coronavirus disease 2019 (COVID-19) caused by SARS-CoV- 2, in individuals12 years of age and older.,The use of this vaccine should be in accordance with official recommendations.,The decision has been made on the basis of short term immunogenicity and safety data. Continued approval depends on the evidence of longer term efficacy and safety from ongoing clinical trials and post-market assessment.
How to use this medicine
(ARTG)
This medicine contains one component only.
Component :
- Injection, suspension
- Intramuscular
- white to off-white frozen suspension
Storage conditions
(ARTG)
- Store between minus 60 - minus 90 degrees
- Protect from Light
- See Product information for shelf life
- Shelf lifetime is 24 Months.
Do I need a prescription ?
(ARTG)
These medicine packs are available from a pharmacist and requires a prescription. It is
- 10 pack
- 195 pack
Pregnant or planning a pregnancy ?
(AHT)
For the active ingredient tozinameran + famtozinameran
You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.
Reporting side effects
This medicine is under additional monitoring as it is new or being used in a different way. You can help identify new safety information by reporting any side effects you may get.
- You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems.
- For more information on the Black Triangle Scheme and how to report side effects, see www.tga.gov.au/black-triangle-scheme
Need more information?
These trusted information partners have more on this topic.
Top results
COVID-19 vaccines: Frequently asked questions (FAQs) | NCIRS
COVID-19 vaccines: Frequently asked questions (FAQs) COVID-19 Australian Immunisation Handbook COVID-19 vaccines Immunisation coverage data and reports Education and training History of immunisation Immunisation schedules National and international resources NCIRS fact sheets, FAQs and other resources COVID-19 DTPa-HB-IPV-Hib vaccine (Vaxelis® and Infanrix hexa®) Haemophilus influenzae type b (Hib) Hepatitis B Human papillomavirus Influenza Japanese encephalitis Measles Measles vaccination catch-up guide Meningococcal Mpox (formerly known as monkeypox) Mumps Pertussis Pneumococcal Poliomyelitis Respiratory syncytial virus (RSV) Rotavirus Rubella Varicella-zoster (chickenpox) Zoster (shingles) Injection site reactions Vaccine components Vaccines for Australian adults Vaccinations during pregnancy NCIRS webinar series Patient communication resources Specialist immunisation services SKAI - supporting health professionals NCIRS newsletters Vaccine safety COVID-19 Australian Immunisation Handbook COVID-19 vaccines Immunisation coverage data and reports Education and training History of immunisation Immunisation schedules National and international resources NCIRS fact sheets, FAQs and other resources COVID-19 DTPa-HB-IPV-Hib vaccine (Vaxelis® and Infanrix hexa®) Haemophilus influenzae type b (Hib) Hepatitis B Human papillomavirus Influenza Japanese encephalitis Measles Measles vaccination catch-up guide Meningococcal Mpox (formerly known as monkeypox) Mumps Pertussis Pneumococcal Poliomyelitis Respiratory syncytial virus (RSV) Rotavirus Rubella Varicella-zoster (chickenpox) Zoster (shingles) Injection site reactions Vaccine components Vaccines for Australian adults Vaccinations during pregnancy NCIRS webinar series Patient communication resources Specialist immunisation services SKAI - supporting health professionals NCIRS newsletters Vaccine safety Key points COVID-19 is a disease caused by the SARS-CoV-2 virus
Read more on National Centre for Immunisation Research and Surveillance (NCIRS) website
Top results
COVID-19 vaccines in 2023 - Australian Prescriber
As SARS‑CoV‑2 continues to evolve, vaccines are being updated, and policymakers are reviewing the optimal timing of future booster doses to maintain adequate protection against severe illness, particularly for older adults.
Read more on Australian Prescriber website
Vaccination During Pregnancy Guide - Immunisation Coalition
About Pregnancy And Vaccinations Whooping Cough Vaccination During Pregnancy Influenza Vaccination During Pregnancy COVID-19 Vaccination During Pregnancy RSV Vaccination During Pregnancy RSV Prevention In High-Risk Infants Download the Guide pdf About Pregnancy And Vaccinations People are particularly vulnerable during pregnancy and should receive the influenza vaccine, the whooping cough (pertussis) vaccine, and now a COVID-19 vaccine and an RSV vaccine to protect themselves and their baby
Read more on Immunisation Coalition website
COVID-19 Guide - Immunisation Coalition
About COVID-19 COVID-19 Cause And Transmission COVID-19 Symptoms COVID-19 Complications COVID-19 Prevention COVID-19 Vaccine Efficacy COVID-19 Vaccine Safety How Is COVID-19 Treated? About COVID-19 Coronavirus disease (COVID-19) is an infectious disease caused by the SARS-CoV-2 virus
Read more on Immunisation Coalition website
